RASI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 852
EU - Europa 848
AS - Asia 204
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 3
Totale 1.918
Nazione #
US - Stati Uniti d'America 842
IE - Irlanda 246
DE - Germania 160
SE - Svezia 153
IT - Italia 117
UA - Ucraina 85
CN - Cina 67
FI - Finlandia 50
IN - India 43
SG - Singapore 43
HK - Hong Kong 42
GB - Regno Unito 19
EU - Europa 11
CA - Canada 10
IR - Iran 8
BE - Belgio 4
NL - Olanda 3
CL - Cile 2
CZ - Repubblica Ceca 2
FR - Francia 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CH - Svizzera 1
ES - Italia 1
GR - Grecia 1
LT - Lituania 1
PE - Perù 1
Totale 1.918
Città #
Dublin 246
Jacksonville 166
Dearborn 94
Wilmington 91
Chandler 84
Hong Kong 42
Boardman 33
Piemonte 30
Lawrence 29
Princeton 29
San Mateo 27
Bremen 25
Beijing 24
Singapore 22
Ann Arbor 20
Andover 17
Ashburn 16
Grafing 13
Hefei 9
Düsseldorf 7
Nanjing 7
Toronto 7
Novara 6
Turin 5
Berlin 4
Brussels 4
Florence 4
Guangzhou 4
Jinan 4
Kunming 4
Leawood 4
London 4
Norwalk 4
West Jordan 4
Houston 3
Milan 3
Munich 3
Sacramento 3
Seattle 3
Trieste 3
Zanjan 3
Bangalore 2
Brno 2
Casalecchio Di Reno 2
Castel Gandolfo 2
Castellazzo Bormida 2
Helsinki 2
Kemerovo 2
Santa Clara 2
Shaoxing 2
Trento 2
Winnipeg 2
Wuhan 2
Amsterdam 1
Augusta 1
Baoding 1
Bologna 1
Cardano 1
Cassano Magnago 1
Chengdu 1
Denia 1
Fairfield 1
Fuzhou 1
Gunzenhausen 1
Hanover 1
Harbin 1
Henderson 1
Hyderabad 1
Köln 1
Leipzig 1
Lima 1
Nanchang 1
Nice 1
Ottawa 1
Palmetto 1
Perugia 1
Quarto D'asti 1
Storrs Mansfield 1
Strasbourg 1
Taiyuan 1
Torino 1
Trani 1
Treviso 1
Villavesco 1
Visp 1
Wenzhou 1
Woodbridge 1
Totale 1.168
Nome #
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 112
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 102
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 79
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 77
Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome 74
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 73
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome 72
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 72
ASSOCIATION BETWEEN MOLECULAR LESIONS AND SPECIFIC B-CELL RECEPTOR SUBSETS IN CHRONIC LYMPHOCYTIC LEUKEMIA 71
CLINICAL IMPACT OF SMALL TP53 MUTATED SUBCLONES IN CHRONIC LYMPHOCYTIC LEUKEMIA 71
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 70
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 69
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 67
Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance. 66
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 65
Analysis of NOTCH1 mutations in monoclonal B cell lymphocytosis 62
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 62
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 61
An update on: molecular genetics of high-risk chronic lymphocytic leukemia 59
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 57
GENETIC LESIONS ASSOCIATED WITH CHRONIC LYMPHOCYTIC LEUKEMIA CHEMO-REFRACTORINESS 57
Molecular history of Richter syndrome: Origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis 56
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation 55
Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia 52
THE HOST GENETIC BACKGROUND OF DNA REPAIR MECHANISMS IS AN INDEPENDENT PREDICTOR OF PROGRESSION AND OVERALL SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA 52
RICHTER SYNDROME: FROM MOLECULAR GENETIC TO THERAPEUTIC STRATEGIES 51
Saliva is a reliable and practical source of germline DNA for genome-wide studies in chronic lymphocytic leukemia 50
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 43
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome 40
NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL 40
Prognostic value of clonal evolution identified by sequential FISH in untreated chronic lymphocytic leukaemia 13
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 13
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 8
Totale 1.971
Categoria #
all - tutte 11.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.232


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020290 0 0 0 0 0 57 72 26 33 71 29 2
2020/2021193 33 3 28 0 28 2 28 2 33 5 31 0
2021/2022257 1 2 24 33 25 1 29 3 20 20 46 53
2022/2023558 31 30 51 4 46 51 23 21 244 0 39 18
2023/2024258 21 17 15 5 35 6 38 12 0 5 23 81
2024/202577 12 6 19 8 23 9 0 0 0 0 0 0
Totale 1.971